With up to 97% of respiratory infection cases remaining undiagnosed and a significant risk of future pandemics, earlier and faster diagnosis is key to reducing the spread of emerging viral infections, enabling timely treatment and mitigating their burden.
Our non-invasive, automated, and real-time devices identify common respiratory infections from a single exhalation, even before the manifestation of symptoms. By combining the high accuracy and reliability of molecular diagnostics with the portability and rapid analysis capabilities of point-of-care solutions, we are making diagnostics faster, more accessible and scalable, significantly reducing the burden on healthcare systems.
VAir is incubated at the Drahi-X Novation Center as part of its X-Up Create programme, and is a member of the École Polytechnique ecosystem.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 2, Rue Alfred Nobel, Champs-Sur-Marne,île-De-France 77420,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://vair.dev
- HQ
- Champs-sur-Marne, Île-de-France
Vair Questions
Vair's website is https://vair.dev
Vair's LinkedIn profile is https://fr.linkedin.com/company/vair-biotech
Vair has
7 employees.
View email and phone details for 7
employees at Vair.
Vair's industry is
Biotechnology Research
Vair's top competitors are
Virtuosis Ai,
Relogate,
Femnov,
Simaptic,
Archismart Solar,
O-Techno,
Sanomoov,
Missia Care,
Austral Dx,
Jane.
Vair's categories are Biotechnology Research
Vair's founding year is 2024
